Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 32Metastatic Castration-resistant Prostate Cancer 4Kidney Neoplasms 3Prostatic Neoplasms, Castration-Resistant 2Carcinoma, Renal Cell 2Urogenital Neoplasms 1Thrombocytopenia 1Renal Insufficiency 1Prostatic Diseases 1Prostate Cancer Metastatic 1PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy 1Neoplasms by Site 1Neoplasms 1Metastatic Hormone Naive Prostate Cancer 1Metastatic Castration Resistant Prostate Cancer (mCRPC) 1Metastatic Castrate Resistant Prostate Cancer (mCRPC) 1Male Urogenital Diseases 1Liver Neoplasms 1High-Risk Localized Prostate Cancer 1Glioma 1Glioblastoma 1Genital Neoplasms, Male 1Disease 1Cytopenia 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Hepatocellular 1Carcinoma 1Astrocytoma 1Anemia 1

Interventions

Specimen Handling 9Nivolumab 9Ipilimumab 7cabozantinib 6CTLA-4 Antigen 6pembrolizumab 5Magnetic Resonance Spectroscopy 5Biopsy 4Axitinib 4lenvatinib 2fludarabine 2Blood Specimen Collection 2tivozanib 1sodium-iodide symporter 1sitravatinib 1belzutifan 1aldesleukin 1Zoledronic Acid 1Tissue Banks 1Selenomethionine 1Radiotherapy 1Radiopharmaceuticals 1Pluvicto 1Nephrectomy 1Metastasectomy 1Inulin 1Immunoglobulin G 1Ibandronic Acid 1Hyaluronoglucosaminidase 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Clear-cell metastatic renal cell carcinoma × Pluvicto × 1 year × Clear all
NCT06783348 2026-06-04

RENALUT

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting
48 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡